Skip to content
★ Sign in to follow
Total declarations
20
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (18 ops.)
€7.8M

Latest filing published 18 Jan 2023 for Madrigal Pharmaceuticals, INC..

Filing timeline

BuySale
Remy Sukhija

Insider track record

Disclosed buys
0
Disclosed sells
18
Signal history

Remy Sukhija: trading record in brief

Remy Sukhija is a declared insider of Madrigal Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Between 23 December 2022 and 16 January 2023, the trades on record add up to 20 filings.

On the market, this insider has only sold: 18 sales, €7.8M in total. Besides market trades, the filings include 1 share grant and 1 option exercise.

The record was last updated on 18 January 2023 with a share grant in Madrigal Pharmaceuticals, Inc. Typically, a trade is published a median of 5 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Remy Sukhija

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total

20 of 20 declarations